Prelude Capital Management’s Aveanna Healthcare AVAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-14,500
Closed -$124K – 1368
2026
Q2
$124K Sell
14,500
-24,146
-62% -$170K 0.01% 1078
2026
Q1
$249K Buy
38,646
+708
+2% +$5.47K 0.02% 799
2025
Q4
$310K Buy
37,938
+6,317
+20% +$57.1K 0.02% 779
2025
Q3
$280K Buy
31,621
+4,385
+16% +$27.7K 0.02% 767
2025
Q2
$142K Buy
27,236
+13,408
+97% +$68.2K 0.01% 864
2025
Q1
$74.9K Buy
+13,828
New +$65.2K 0.01% 1064
2022
Q2
– Sell
-33,900
Closed -$116K – 1810
2022
Q1
$116K Sell
33,900
-12,400
-27% -$67.3K ﹤0.01% 1383
2021
Q4
$343K Buy
46,300
+300
+0.7% +$2.18K 0.01% 1237
2021
Q3
$369K Sell
46,000
-1,793
-4% -$17.4K 0.01% 1037
2021
Q2
$591K Buy
+47,793
New +$567K 0.02% 858

Other funds holding AVAH

Prelude Capital Management's AVAH Position: Q3 2026 in Review

Prelude Capital Management sold out of Aveanna Healthcare (AVAH) in Q3 2026, closing a stake of 14,500 shares — an estimated $124K sold.

Prelude Capital Management first reported a position in AVAH in Q2 2021 and held it in 10 quarters. The position peaked at $591K in Q2 2021. 261 funds tracked by Wall St. Rank hold AVAH as of Q3 2026.

  • Prelude Capital Management reported no remaining Aveanna Healthcare position as of Q3 2026 after selling out during the quarter.
  • Prelude Capital Management sold 14,500 Aveanna Healthcare shares in Q3 2026, an estimated $124K.
  • Prelude Capital Management first reported a position in Aveanna Healthcare in Q2 2021 and held it in 10 quarters.
  • Prelude Capital Management's Aveanna Healthcare position peaked at $591K in Q2 2021.
  • 261 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q3 2026.

Based on Prelude Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.